Revising EU pharmaceutical legislation: will it foster drug repurposing?
- DOI
- 10.1016/j.drudis.2024.104286
- Published
- 2025 Jan
- Container
- Drug discovery today
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.drudis.2024.104286,
title = {Revising EU pharmaceutical legislation: will it foster drug repurposing?},
author = {Scholte M and Grimm SE and Pauly B and Verbeeck F and Pasmooij AMG and Bouma B and van Duijn-Wiersma J and Guney E and Kesselheim AS and Schmidt HHHW and Joore MA},
year = {2025},
journal = {Drug discovery today},
doi = {10.1016/j.drudis.2024.104286},
url = {https://doi.org/10.1016/j.drudis.2024.104286}
}RIS
TY - JOUR TI - Revising EU pharmaceutical legislation: will it foster drug repurposing? AU - Scholte M AU - Grimm SE AU - Pauly B AU - Verbeeck F AU - Pasmooij AMG AU - Bouma B AU - van Duijn-Wiersma J AU - Guney E AU - Kesselheim AS AU - Schmidt HHHW AU - Joore MA PY - 2025 JO - Drug discovery today DO - 10.1016/j.drudis.2024.104286 UR - https://doi.org/10.1016/j.drudis.2024.104286 ER -
APA
M, S., SE, G., B, P., F, V., AMG, P., B, B., J, V. D., E, G., AS, K., HHHW, S., & MA, J. (2025). Revising EU pharmaceutical legislation: will it foster drug repurposing?. Drug discovery today. https://doi.org/10.1016/j.drudis.2024.104286
Source records
- pubmed · retrieved 2026-09-26T08:44:31.452Z